Nature Immunology
- 7, 1157 - 1165 (2006)
Published online: 1 October 2006; | doi:10.1038/ni1398
A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell toleranceLequn Li1, Yoshiko Iwamoto1, Alla Berezovskaya2 & Vassiliki A Boussiotis1, 31
Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA. 2
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02129, USA. 3
Department of Medicine Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA.
Correspondence should be addressed to vboussiotis@partners.org Peripheral tolerance is essential for immunological homeostasis. Tolerant T cells are thought to arise after T cell receptor ligation in conditions that are nonpermissive for replication. Here we have investigated the function of the cell cycle inhibitor p27Kip1 in tolerance induction in vivo using naive T cell receptor–transgenic cells lacking the cyclin-dependent kinase (Cdk)–binding domain of p27Kip1(p27 ). Wild-type but not p27 cells underwent tolerization. Tolerized wild-type cells had impaired Cdk2 and Cdc2 kinase activity and failed to phosphorylate the checkpoint inhibitor Smad3, leading to enhanced expression of the Cdk inhibitor p15. In contrast, p27 cells proliferated in tolerizing conditions because of Cdk kinase activation and phosphorylation of Smad3, which resulted in no upregulation of p15. Smad3 'knockdown' prevented tolerance induction, whereas expression of a Smad3 mutant resistant to Cdk-mediated phosphorylation recapitulated molecular and functional events of tolerance. Thus, p27Kip1 is required during induction of tolerance and Smad3 regulates T cell responses 'downstream' of p27Kip1.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
